Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
Department of Urology, Texas Tech University Health Science Center, Lubbock, TX.
Clin Genitourin Cancer. 2017 Dec;15(6):670-677.e1. doi: 10.1016/j.clgc.2017.04.019. Epub 2017 Apr 26.
Evidence supports upfront regional lymphadenectomy (rND) when primary penile tumors exhibit high-risk features and negative inguinal adenopathy (cN0). We sought to analyze trends in the utilization of early rND as well as assess factors associated with its use and survival outcomes using a nationwide cancer registry database.
The National Cancer Database was queried for patients with clinically nonmetastatic penile carcinoma and available nodal status who underwent rND from 1998 to 2012. Temporal trends in the utilization of early rND for those with cN0 disease were analyzed, and a multivariable logistic regression model was used to identify predictors for receiving rND. Survival analysis based on rND status was performed using the Kaplan-Meier method and Cox proportional hazard regression.
From 1919 patients with available clinicopathologic variables, performance of early rND was documented in 377 (19.6%) patients with an increase in utilization over time (P = .001). The increase was driven by academic and comprehensive cancer programs compared with community programs (P < .001). Positive predictors were treatment facility, clinical tumor stage, and grade (all P < .05). African American patients (odds ratio [OR], 0.53; 95% confidence interval [CI], 0.33-0.86; P = .01) and those aged > 75 years (OR, 0.42; 95% CI, 0.26-0.68; P < .001) were significantly less likely to receive rND. Early rND was associated with improved overall survival (hazard ratio [HR], 0.67; 95% CI, 0.52-0.87; P = .003).
There was increased use of early lymphadenectomy for patients with cN0 penile cancer driven by comprehensive and academic cancer programs. The study demonstrated demographic and socioeconomic differences that can help identify barriers to care for patients with penile cancer in the United States.
当原发性阴茎肿瘤具有高危特征且腹股沟淋巴结无转移(cN0)时,证据支持进行 upfront regional lymphadenectomy(rND)。我们试图通过国家癌症登记数据库分析早期 rND 的应用趋势,并评估其应用与生存结果相关的因素。
本研究通过国家癌症数据库,对 1998 年至 2012 年间患有临床非转移性阴茎癌且淋巴结状态可查、接受 rND 的患者进行了查询。分析了 cN0 疾病患者早期 rND 应用的时间趋势,并使用多变量逻辑回归模型确定接受 rND 的预测因素。采用 Kaplan-Meier 法和 Cox 比例风险回归进行基于 rND 状态的生存分析。
在 1919 例具有可用临床病理变量的患者中,377 例(19.6%)患者记录了早期 rND 的应用,且应用呈时间趋势增加(P =.001)。这种增加是由学术和综合性癌症项目驱动的,而不是社区项目(P <.001)。阳性预测因素为治疗机构、临床肿瘤分期和分级(均 P <.05)。非裔美国患者(比值比 [OR],0.53;95%置信区间 [CI],0.33-0.86;P =.01)和年龄 > 75 岁的患者(OR,0.42;95% CI,0.26-0.68;P <.001)rND 应用的可能性明显降低。早期 rND 与总生存改善相关(风险比 [HR],0.67;95% CI,0.52-0.87;P =.003)。
综合性和学术性癌症项目推动了 cN0 阴茎癌患者早期淋巴结切除术的应用增加。该研究表明了美国患者在护理方面存在的人口统计学和社会经济差异,有助于确定这些患者的治疗障碍。